Unfortunately the immune globulin is not uniformly protective, and is not
licensed in the US for any postexposure purposes for HCV. I would recommend
continuing your current practices, although it should be reassuring for you
know that the risk of sexual transmission of HCV is quite low (<5% in the
majority of studies) even in the absence of these practices.